- Published on
Diagnostic Tests – PSA (Prostate-Specific Antigen)
1. What Is PSA?
Prostate-specific antigen (PSA) is a protein produced almost exclusively by prostatic epithelial cells. It circulates in the bloodstream at low levels in healthy men but can rise in a variety of prostate-related conditions. PSA is not specific for prostate cancer—it increases in benign prostatic hyperplasia (BPH), prostatitis, urinary retention, recent ejaculation, and even after prostate manipulation such as digital rectal exam or biopsy. After a total prostatectomy, PSA should fall to undetectable levels; therefore, any measurable PSA in this setting suggests persistent or recurrent disease. Because PSA reflects prostate activity, but not necessarily malignancy, it requires careful interpretation.
2. When Should PSA Testing Be Done?
Routine PSA screening is controversial because large population studies have not clearly demonstrated a reduction in prostate cancer–related mortality. As a result, board-style questions emphasize that PSA screening is not routinely recommended for asymptomatic men. However, if a patient specifically requests the test for reassurance or personal preference, it is appropriate to perform it after discussing risks and limitations. Thus, in test scenarios, PSA should be ordered when the patient actively asks for screening, or when it is part of the evaluation of known or suspected prostate pathology.
3. What Is the Most Accurate Test?
The most accurate diagnostic test for confirming prostate cancer is a prostate biopsy. Neither PSA nor imaging can definitively diagnose malignancy—only histologic examination can determine the presence and grade of cancer. Biopsy results not only establish the diagnosis but also provide Gleason scoring, which guides prognosis and management decisions.
4. What Test Is Done Next If PSA Is Elevated?
When a PSA level is elevated, the next step is to perform a digital rectal exam (DRE) to assess the prostate directly. If the DRE reveals a palpable nodule, area of induration, or asymmetry, the abnormal region should be biopsied. If the DRE is normal but PSA is persistently elevated or concerning, the next step is a transrectal ultrasound (TRUS) to visualize the prostate and identify areas to target for biopsy. If no clear lesion is detected despite high PSA levels, clinicians may proceed with systematic (“blind”) biopsies, sampling multiple regions of the prostate because cancer can be present even without a detectable mass.
1. What Is PSA?
Prostate-specific antigen (PSA) is a protein produced almost exclusively by prostatic epithelial cells. It circulates in the bloodstream at low levels in healthy men but can rise in a variety of prostate-related conditions. PSA is not specific for prostate cancer—it increases in benign prostatic hyperplasia (BPH), prostatitis, urinary retention, recent ejaculation, and even after prostate manipulation such as digital rectal exam or biopsy. After a total prostatectomy, PSA should fall to undetectable levels; therefore, any measurable PSA in this setting suggests persistent or recurrent disease. Because PSA reflects prostate activity, but not necessarily malignancy, it requires careful interpretation.
2. When Should PSA Testing Be Done?
Routine PSA screening is controversial because large population studies have not clearly demonstrated a reduction in prostate cancer–related mortality. As a result, board-style questions emphasize that PSA screening is not routinely recommended for asymptomatic men. However, if a patient specifically requests the test for reassurance or personal preference, it is appropriate to perform it after discussing risks and limitations. Thus, in test scenarios, PSA should be ordered when the patient actively asks for screening, or when it is part of the evaluation of known or suspected prostate pathology.
3. What Is the Most Accurate Test?
The most accurate diagnostic test for confirming prostate cancer is a prostate biopsy. Neither PSA nor imaging can definitively diagnose malignancy—only histologic examination can determine the presence and grade of cancer. Biopsy results not only establish the diagnosis but also provide Gleason scoring, which guides prognosis and management decisions.
4. What Test Is Done Next If PSA Is Elevated?
When a PSA level is elevated, the next step is to perform a digital rectal exam (DRE) to assess the prostate directly. If the DRE reveals a palpable nodule, area of induration, or asymmetry, the abnormal region should be biopsied. If the DRE is normal but PSA is persistently elevated or concerning, the next step is a transrectal ultrasound (TRUS) to visualize the prostate and identify areas to target for biopsy. If no clear lesion is detected despite high PSA levels, clinicians may proceed with systematic (“blind”) biopsies, sampling multiple regions of the prostate because cancer can be present even without a detectable mass.
0 Comments
